5 Best S&P 500 Stocks To Buy According to Analysts

3. Biogen Inc. (NASDAQ:BIIB)

Number of Q4 2023 Hedge Fund Shareholders: 51

Average Analyst Share Price Target: $304

Percentage Upside: 41.09%

Biogen Inc. (NASDAQ:BIIB) is a sizeable drug manufacturer that makes and sells medicines used to treat nervous system disorders and other ailments. The firm is in store for an interesting couple of months, as it waits for the EU’s analysis of its drug for Alzheimer’s Disease developed in partnership with a Japanese firm.

Insider Monkey dug through 933 hedge fund portfolios for last year’s fourth quarter and found 51 Biogen Inc. (NASDAQ:BIIB) shareholders. Samuel Isaly’s OrbiMed Advisors owned the biggest stake which was worth $214 million.

Follow Biogen Inc. (NASDAQ:BIIB)